Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03162562
Recruitment Status : Active, not recruiting
First Posted : May 22, 2017
Last Update Posted : May 22, 2019
Sponsor:
Information provided by (Responsible Party):
OncoQuest Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2021